GEM
PFE icon

Global Endowment Management’s Pfizer PFE Stock Holding History

Global Endowment Management’s Portfolio PFE Stock Details PFE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-9,130
Closed -$231K – 147
2025
Q1 		$231K Buy
+9,130
New +$239K 0.03% 130
2018
Q2 		– Sell
-124,688
Closed -$4.2M – 232
2018
Q1 		$4.2M Buy
+124,688
New +$4.29M 0.6% 34
2017
Q4 		– Sell
-100,235
Closed -$3.4M – 223
2017
Q3 		$3.4M Sell
100,235
-3,268
-3% -$105K 0.48% 37
2017
Q2 		$3.3M Buy
+103,503
New +$3.26M 0.45% 39

Other funds holding PFE

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
State Farm Mutual Automobile Insurance
State Farm Mutual Automobile Insurance Bloomington, Illinois $127B AUM 32.55% 1-Year Est. Return

Global Endowment Management's PFE Position: Q2 2025 in Review

Global Endowment Management sold out of Pfizer (PFE) in Q2 2025, closing a stake of 9,130 shares — an estimated $231K sold.

Global Endowment Management first reported a position in PFE in Q2 2017 and held it in 4 quarters. The position peaked at $4.2M in Q1 2018. 2,809 funds tracked by Wall St. Rank hold PFE as of Q2 2025.

  • Global Endowment Management reported no remaining Pfizer position as of Q2 2025 after selling out during the quarter.
  • Global Endowment Management sold 9,130 Pfizer shares in Q2 2025, an estimated $231K.
  • Global Endowment Management first reported a position in Pfizer in Q2 2017 and held it in 4 quarters.
  • Global Endowment Management's Pfizer position peaked at $4.2M in Q1 2018.
  • 2,809 funds tracked by Wall St. Rank held Pfizer as of Q2 2025.

Based on Global Endowment Management's 13F filing for Q2 2025, filed 13 Aug 2025.